SECOND TEAM
Holger Blum, Yi-Dan Wang & team Deutsche Bank
Runner-up last year, the Deutsche Bank trio conducted by Holger Blum, who works out of Zurich, and London-based Yi-Dan Wang take second place. The analysts offer “unbeatable access to the German-speaking medical establishment” and “great stock picking,” money managers say. Throughout last year the researchers highlighted their contrarian buy rating on Galenica, telling clients that the market was too negative on the Berne, Switzerland–based company’s dialysis business. The stock advanced 56.4 percent in 2010, from Sf361.25 to Sf565, and bested the sector by 50.2 percentage points.